were excluded. Pertinent baseline demographic, perioperative, and pathologic data were reviewed retrospectively using patient charts. late (2008) (2009) (2010) (2011) (2012) (2013) (2014) . These time periods were chosen to ensure equal cohort size. In addition, based on the well-known observation that it takes several years for published data and guidelines to be widely adopted into clinical practice, 14 the authors believed that 8 years was an appropriate timeframe to assess changes in diagnostic patterns.
Statistical analyses were conducted using SPSS 22.0 software (IBM Inc., Armonk, NY). Male and female patients who underwent pancreatic resection for MCN were compared using chi-squared analysis for categorical variables, and Student's t-test for continuous variables. Statistical significance was predefined as two-tailed P < 0.05.
| RESULTS
Of 1667 patients who underwent resection of a pancreatic cystic neoplasm, 349 (21%) had MCNs. The remaining cystic neoplasms that were excluded from analysis were: IPMN (n = 586), serous cystadenoma (n = 227), cystic adenocarcinoma (n = 132), pseudocyst (n = 122), pseudopapillary tumor (n = 86), and other (n = 165).
Of the 349 MCN patients, 310 (89%) were female and 39 (11%)
were male. Clinicopathologic comparisons between male and female patients are shown in Table 1 . Male patients were older than female patients (65 yrs vs. 52 yrs; P < 0.001), and were more likely to present with jaundice (11 vs. 1%; P = 0.001), have lesions located in the head of the pancreas (49 vs. 11%; P < 0.001), and display pancreatic ductal dilatation on pre-operative imaging (42 vs. 14%; P < 0.001). Male patients also more frequently underwent pancreaticoduodenectomy compared to female patients (46 vs. 10%; P < 0.001), although distal pancreatectomy was still the most common procedure performed in both groups. Adenocarcinoma and/or high-grade dysplasia was identified within surgical specimens in 39% of male patients and 12%
of female patients (P < 0.001). Lymph node positive disease was identified in 57% of male patients and 22% of female patients (P = 0.04).
Patients were divided by surgery date into early (2000-2007; n = 173, 50%) and late (2008) (2009) (2010) (2011) (2012) (2013) (2014) ; n = 176, 50%) time periods (Fig. 1 ).
There was a decrease from the Early to Late time periods in the proportion of MCN patients who were male (15 vs. 7%; P = 0.04) and of MCNs located in the pancreatic head/neck (22 vs. 11%; P = 0.01). There was no difference in the proportion of MCNs associated with AC/HGD between the early and late groups (17 vs. 13%; P = 0.41). On stratumspecific analysis by gender, the proportion of male MCN patients with associated AC/HGD remained stable at 39% over both time periods.
| DISCUSSION
Mucinous cystic neoplasms are one of the most common types of cystic neoplasms of the pancreas, and are primarily found in the pancreatic body and tail of premenopausal women. 1,2 Although uncommon, MCNs are still reported in males, even using modern diagnostic criteria, yet few studies focus on this rare and unique group of patients. [11] [12] [13] In this study, we utilized a large, multi-institutional database to investigate the clinicopathologic characteristics of MCNs diagnosed in male compared to female patients, and assessed This finding has led some to adopt the belief that MCNs are exclusive to only female patients, and any male patient with an MCN diagnosis likely has a misclassified IPMN. Yet the continued emergence of modern case reports and case series of male patients with histologically confirmed MCN based on the presence of ovarian stroma, demonstrates that, while rare, this population does, in fact, exist. [11] [12] [13] 16, 17 Although the specific pathogenesis of MCNs is unclear, it is believed to be hormonally mediated, and in a study by Regi et al., 16 nearly 50% of the male patients with histologically confirmed MCN were found to have hormonal and/or sexual dysfunction. 
